Skip to content

CalAmp CAMP Free cash flow margin

Free cash flow margin at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-77.4%+35.3pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
36.2%+18.4pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-441.5%-126pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,503.6%+621pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-225.6%-334pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-28.7%-9.2pp

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

Based on trailing twelve months.

The official record: CalAmp’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's free cash flow margin?
CalAmp (CAMP) reported free cash flow margin of -1,254% in Q3 2025.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.